BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 19663594)

  • 1. Stimulus-responsive targeted nanomicelles for effective cancer therapy.
    Muthu MS; Rajesh CV; Mishra A; Singh S
    Nanomedicine (Lond); 2009 Aug; 4(6):657-67. PubMed ID: 19663594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
    Cheng R; Meng F; Deng C; Klok HA; Zhong Z
    Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward therapeutic delivery with layer-by-layer engineered particles.
    Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
    ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
    van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
    Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle therapeutics for prostate cancer treatment.
    Sanna V; Sechi M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy.
    Hamidi M; Shahbazi MA; Rostamizadeh K
    Macromol Biosci; 2012 Feb; 12(2):144-64. PubMed ID: 22006795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
    Parhi P; Mohanty C; Sahoo SK
    Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
    Liu G; Lovell JF; Zhang L; Zhang Y
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.